NEWCaplight raises a $16M Series A, led by BlackRock and Fin Capital →
Skip to main content
Caplight Logo









SkyDance Vascular, Inc.

SkyDance Vascular, Inc.

Private
Delray Beach, FloridaHealthcare & Life Scienceshttps://www.skydancevascular.com/

Last Round

Seed

Dec 16, 2021

Total Funding Raised

$5.8M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

SkyDance Vascular, Inc. is a medical device company that develops and commercializes peripheral intravenous catheter systems utilizing proprietary through-the-needle technology to improve clinical outcomes and patient safety.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices

Business Model

B2B

Customer Profile

Hardware Sales

AI Layer

Non-AI

Keywords

PIVCperipheral intravenous cathetervascular accessmidline catheterthrough-the-needleclosed-system cathetermedical device manufacturercatheter insertioninfection controlIV safetyvascular access devicehospital suppliesneedlestick preventionclinical outcomesANTT compliance

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

SkyDance Vascular, Inc. Comps

Public and private peers based on sector, stage, and business model.

SkyDance Vascular, Inc. comps — public and private peers by sector, stage, and business model
CompanyStatusEst. ValuationRev Multiple
OpenAIPrivate$86.0B~40x
CoherePrivate$5.0B--
Competitor 1Public$XX.XBXXx
Competitor 2Public$XX.XBXXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

SkyDance Vascular, Inc. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
SeedDec 16, 2021
SeedOct 27, 2020

Key People

Founding team and executive leadership

David Wirthlin

Co-Founder And CFO

Founding Team

Michael Anstett

Founder, Chief Clinical Officer

Founding Team

Bill Bold

Chief Executive Officer

Executive Team

John Kujawa

Chief Technology Officer

Executive Team

SkyDance Vascular, Inc. Investors

Notable investors and investment history

SkyDance Vascular, Inc. investors
InvestorRounds
MedFocus FundSeed

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 20, 2026

    Monthly visitors increased 560% to 449.

SkyDance Vascular, Inc. Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

SkyDance Vascular, Inc. Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about SkyDance Vascular, Inc.'s valuation, stock price, and market status.

Firmographic Details

HeadquartersDelray Beach, Florida
Employee Range8
Year Founded2017
Last FundingDec 16, 2021

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.